AMFR and sarcoma: Using an epitope-defined antibody raised against a known peptide sequence in the C-terminus of gp78 (13, 14, 24), it was later found that gp78 specifically targets the tumor suppressor protein CD82 for degradation in sarcoma cells, thus providing the first implication of a role for gp78 in human cancers (24).